ABT - Adjustment

The following adjustment was made today on Abbott Laboratories (ABT). All prices include IB commissions.

This is the second position on ABT.

Criteria	Value
Dividend Champions Status	Champion
Years of Consecutive Dividend Increases	38
Years of Positive Free Cash Flow (last 10 years)	10
Fair Value Estimate	$68.00
Target Buy Price	$55.00
Target Margin of Safety	20.00%
Actual Buy Price	$52.50
Actual Margin of Safety	22.79%

Date	Stock	Description	Transaction	Status	Stock Investment	Income Generated
10/31/2011	ABT	Continued Trade	STO 1 Jan12 52.50 Put @ 1.44			$144.12

Current Position Summary

Cost Basis	($5,250.00)
Income Generated	$436.40
Percent Income Generated	8.31%
Annualized Income Generated	12.33%
Net Profit If Assigned	$436.40
Percent Return If Assigned	8.31%
Annualized Return If Assigned	12.33%
Days Held to Expiration	246 days

Trade History

Date	Stock	Description	Transaction	Status	Stock Investment	Income Generated
5/19/2011	ABT	CSP Margin Used	CSP 100 ABT @ 52.50		($5,250.00)
5/19/2011	ABT	Initial Put Option	STO 1 Jun11 52.50 Put @ 0.55	Closed		$55.34
6/17/2011	ABT	Buy Back and Roll Out	BTC 1 Jun11 52.50 Put @ -0.82			($81.97)
6/17/2011	ABT	Continued Trade	STO 1 Aug11 52.50 Put @ 2.19	Exercised		$219.03
8/19/2011	ABT	CSP Margin Returned	CSP 100 ABT @ -52.50		$5,250.00
8/19/2011	ABT	Stock Assigned	EX 1 Aug11 52.50 Put @ -52.50		($5,250.00)
8/24/2011	ABT	Continued Trade	STO 1 Oct11 52.50 Call @ 1.00	Exercised		$99.98
10/21/2011	ABT	Stock Called	EX 1 Oct11 52.50 Call @ 52.50		$5,250.00	($0.10)
10/24/2011	ABT	CSP Margin Used	CSP 100 ABT @ 52.50		($5,250.00)
10/31/2011	ABT	Continued Trade	STO 1 Jan12 52.50 Put @ 1.44			$144.12
1/20/2012	ABT		Totals		($5,250.00)	$436.40
DTE	246		Percent Income/Annualized		8.31%	12.33%